Jiang Wenjuan, Hu Yongkang, Wang Xian, Zhang Qi, Guo Xinlong, Cheng Siyu, Chen Langqun, Ying Jiahui, Zhang Liang, Jiang Baoping
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Gene. 2023 Dec 30;889:147806. doi: 10.1016/j.gene.2023.147806. Epub 2023 Sep 15.
Various studies have highlighted the significance of miR-125b-5p in tumour chemotherapy resistance; However, whether miR-125b-5p is associated with all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukemia (APL) has not been reported.
Drug-resistance-related factors in APL were predicted using the DRESIS database. The expression levels of miR-125b-5p in ATRA-sensitive and ATRA-resistant APL cells were determined using quantitative reverse transcription polymerase chain reaction (qRT-PCR). A nitrotetrazolium blue (NBT) reduction assay and flow cytometry (FCM) were used to detect the effect of miR-125b-5p on ATRA resistance in APL cells. An APL xenograft tumour mouse model was established to determine the effect of miR-125b-5p on ATRA resistance. A dual-luciferase gene reporter assay, qRT-PCR, and western blotting verified the regulation by miR-125b-5p of its target gene, MAPK1, and the MAPK1 downstream factor, C/EBPα. An NBT reduction assay and FCM were used to detect the effect of C/EBPα on ATRA resistance in APL cells. Western blotting and qRT-PCR were used to assess the regulation of miR-125b-5p and MAPK1 by C/EBPα.
miR-125b-5p expression levels were dramatically increased in ATRA-resistant APL cells. Both in vitro and in vivo experiments revealed that miR-125b-5p overexpression enhanced ATRA resistance in APL. miR-125b-5p promoted ATRA resistance by sponging MAPK1. C/EBPα was negatively regulated by miR-125b-5p, which in addition, regulated ATRA resistance in APL cells. C/EBPα also regulated the miR-125b-5p-MAPK1 axis.
The findings of this study indicate that the miR-125b-5p-MAPK1-C/EBPα feedback loop regulated ATRA resistance in APL. Thus, miR-125b-5p may be a promising target for treating ATRA resistance in APL.
多项研究强调了miR-125b-5p在肿瘤化疗耐药中的重要性;然而,miR-125b-5p是否与急性早幼粒细胞白血病(APL)中的全反式维甲酸(ATRA)耐药相关尚未见报道。
使用DRESIS数据库预测APL中与耐药相关的因素。采用定量逆转录聚合酶链反应(qRT-PCR)测定miR-125b-5p在对ATRA敏感和耐药的APL细胞中的表达水平。使用硝基四氮唑蓝(NBT)还原试验和流式细胞术(FCM)检测miR-125b-5p对APL细胞中ATRA耐药的影响。建立APL异种移植肿瘤小鼠模型以确定miR-125b-5p对ATRA耐药的影响。双荧光素酶基因报告试验、qRT-PCR和蛋白质印迹法验证了miR-125b-5p对其靶基因MAPK1以及MAPK1下游因子C/EBPα的调控。使用NBT还原试验和FCM检测C/EBPα对APL细胞中ATRA耐药的影响。采用蛋白质印迹法和qRT-PCR评估C/EBPα对miR-125b-5p和MAPK1的调控。
在对ATRA耐药的APL细胞中,miR-125b-5p的表达水平显著升高。体外和体内实验均显示,miR-125b-5p过表达增强了APL对ATRA的耐药性。miR-125b-5p通过靶向MAPK1促进ATRA耐药。miR-125b-5p对C/EBPα具有负调控作用,此外,C/EBPα还调控APL细胞中的ATRA耐药。C/EBPα还调控miR-125b-5p-MAPK1轴。
本研究结果表明,miR-125b-5p-MAPK1-C/EBPα反馈环调控APL中的ATRA耐药。因此,miR-125b-5p可能是治疗APL中ATRA耐药的一个有前景的靶点。